Study: Abdallah 2024, Blood Advances
Febrile neutropenia in patients with Duffy-null-associated neutrophil counts and multiple myeloma or AL amyloidosis
Citation
Abdallah M, Arters F, Patel J, Edwards C et al (2024). Blood Advances. PubMed id 39348709.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- A low white cell count that may be Duffy-null (neutrophil count) Tier B moderate
B Duffy-null Black people and dose decisions (n=0)
Search for trial evidence that Duffy-specific reference ranges are safe.
I found papers on febrile neutropenia in Duffy-null patients with myeloma (Abdallah 2024, abstract not retrievable) and on CDK4/6 inhibitors in breast cancer (Ferri 2025, not opened). I could not confirm trial evidence for safe use of Duffy-specific thresholds. UNVERIFIED.
As recorded in this card: Abdallah M, Arters F, Patel J, Edwards C et al (2024), Blood Advances, [primary]
Note: Title only seen in search; the abstract returned empty from PubMed.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.